ProShares Ultra Health Care (RXL) Holdings
RXL holdings summary
as of Oct 25, 2026- Holdings
- 61 positions listed
- Top 10 weight
- 49.7% of net assets
- Effective holdings
- 14 equal-weight equivalent
- Largest holding
- IQMM 13.47% Proshares Genius Money Market ETF
- Annual turnover
- 19.0% of the portfolio traded
All RXL holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | IQMM | Proshares Genius Money Market ETF | Other | 13.47% | $14.5M | — | — |
| 2 | LLY | Eli Lilly and Company | Healthcare | 9.95% | $10.7M | $1.12T | 42.2 |
| 3 | JNJ | Johnson & Johnson | Healthcare | 6.05% | $6.5M | $615.87B | 38.8 |
| 4 | ABBV | AbbVie Inc. | Healthcare | 4.90% | $5.3M | $504.37B | 80.6 |
| 5 | UNH | UnitedHealth Group Incorporated | Healthcare | 3.71% | $4.0M | $360.32B | 25.8 |
| 6 | MRK | Merck & Co., Inc. | Healthcare | 3.36% | $3.6M | $360.08B | 115.8 |
| 7 | TMO | Thermo Fisher Scientific Inc. | Healthcare | 2.37% | $2.5M | $255.13B | 37.1 |
| 8 | AMGN | Amgen Inc. | Healthcare | 2.24% | $2.4M | $233.82B | 26.9 |
| 9 | GILD | Gilead Sciences, Inc. | Healthcare | 1.90% | $2.0M | $193.67B | — |
| 10 | ABT | Abbott Laboratories | Healthcare | 1.76% | $1.9M | $181.50B | 33.8 |
| 11 | PFE | Pfizer Inc. | Healthcare | 1.74% | $1.9M | $168.60B | 38.9 |
| 12 | ISRG | Intuitive Surgical, Inc. | Healthcare | 1.49% | $1.6M | $150.74B | 48.9 |
| 13 | DHR | Danaher Corporation | Healthcare | 1.37% | $1.5M | $161.01B | 40.8 |
| 14 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 1.26% | $1.4M | $126.66B | 28.9 |
| 15 | BMY | Bristol-Myers Squibb Company | Healthcare | 1.24% | $1.3M | $122.05B | 13.2 |
| 16 | CVS | CVS Health Corporation | Healthcare | 1.20% | $1.3M | $118.13B | 24.3 |
| 17 | MDT | Medtronic plc | Healthcare | 1.20% | $1.3M | $121.20B | 23.3 |
| 18 | MCK | McKesson Corporation | Healthcare | 1.12% | $1.2M | $117.15B | 26.9 |
| 19 | SYK | Stryker Corporation | Healthcare | 1.04% | $1.1M | $113.02B | 30.5 |
| 20 | ELV | Elevance Health Inc. | Healthcare | 0.89% | $958,348.88 | $92.88B | 19.0 |
| 21 | CI | Cigna Corporation | Healthcare | 0.82% | $875,980.70 | $79.88B | 12.5 |
| 22 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 0.79% | $852,247.50 | $81.41B | 19.6 |
| 23 | MRNA | Moderna, Inc. | Healthcare | 0.76% | $814,553.59 | $87.04B | — |
| 24 | BSX | Boston Scientific Corporation | Healthcare | 0.65% | $699,431.45 | $64.33B | 18.0 |
| 25 | HCA | HCA Healthcare, Inc. | Healthcare | 0.64% | $686,652.03 | $99.34B | 15.4 |
| 26 | COR | Cencora | Healthcare | 0.61% | $658,301.06 | $65.06B | 25.3 |
| 27 | CAH | Cardinal Health, Inc. | Healthcare | 0.58% | $622,969.73 | $58.83B | 35.1 |
| 28 | BDX | Becton, Dickinson and Company | Healthcare | 0.54% | $577,865.90 | $52.23B | 44.6 |
| 29 | EW | Edwards Lifesciences Corporation | Healthcare | 0.52% | $561,327.83 | $49.92B | 51.5 |
| 30 | HUM | Humana Inc. | Healthcare | 0.48% | $517,405.30 | $49.61B | 39.1 |
| 31 | A | Agilent Technologies, Inc. | Healthcare | 0.46% | $495,712.51 | $48.77B | 34.1 |
| 32 | WAT | Waters Corporation | Healthcare | 0.45% | $487,550.86 | $42.90B | 110.6 |
| 33 | VEEV | Veeva Systems Inc. | Healthcare | 0.45% | $482,503.53 | $50.25B | 50.9 |
| 34 | IDXX | IDEXX Laboratories, Inc. | Healthcare | 0.44% | $471,871.91 | $44.20B | 39.8 |
| 35 | IQV | IQVIA Holdings Inc. | Healthcare | 0.44% | $471,442.35 | $43.93B | 33.2 |
| 36 | ILMN | Illumina, Inc. | Healthcare | 0.40% | $429,130.67 | $39.64B | 49.0 |
| 37 | CNC | Centene Corporation | Healthcare | 0.36% | $384,026.85 | $34.16B | — |
| 38 | BIIB | Biogen Inc. | Healthcare | 0.36% | $381,556.88 | $34.37B | 41.3 |
| 39 | ZTS | Zoetis Inc. | Healthcare | 0.34% | $366,844.44 | $32.80B | 13.1 |
| 40 | RMD | ResMed Inc. | Healthcare | 0.34% | $363,730.13 | $33.61B | 22.9 |
| 41 | MTD | Mettler-Toledo International Inc. | Healthcare | 0.34% | $363,300.57 | $32.51B | 36.6 |
| 42 | GEHC | GE HealthCare Technologies Inc. | Healthcare | 0.31% | $337,634.34 | $31.42B | 16.0 |
| 43 | DXCM | DexCom, Inc. | Healthcare | 0.29% | $316,478.50 | $32.47B | 34.1 |
| 44 | WST | West Pharmaceutical Services, Inc. | Healthcare | 0.27% | $293,174.86 | $27.03B | 49.4 |
| 45 | DGX | Quest Diagnostics Incorporated | Healthcare | 0.26% | $283,187.58 | $25.94B | 24.6 |
| 46 | LH | Laboratory Corporation of America Holdings | Healthcare | 0.25% | $272,341.19 | $25.79B | 26.3 |
| 47 | STE | STERIS plc | Healthcare | 0.23% | $243,560.65 | $21.71B | 27.2 |
| 48 | VTRS | Viatris Inc. | Healthcare | 0.21% | $226,163.46 | $21.43B | — |
| 49 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | 0.19% | $202,752.43 | $18.12B | 23.1 |
| 50 | INCY | Incyte Corporation | Healthcare | 0.18% | $198,134.66 | $22.92B | 14.4 |
| 51 | RVTY | Revvity, Inc. | Healthcare | 0.17% | $178,052.72 | $17.03B | 73.0 |
| 52 | CRL | Charles River Laboratories International, Inc. | Healthcare | 0.16% | $170,213.24 | $14.46B | — |
| 53 | BAX | Baxter International Inc. | Healthcare | 0.12% | $132,089.77 | $13.07B | — |
| 54 | SOLV | Solventum Corporation | Healthcare | 0.12% | $129,619.80 | $14.61B | 10.5 |
| 55 | COO | The Cooper Companies, Inc. | Healthcare | 0.12% | $128,223.73 | $11.02B | 19.9 |
| 56 | TECH | Bio-Techne Corporation | Healthcare | 0.11% | $122,424.67 | $11.38B | 62.6 |
| 57 | ALGN | Align Technology, Inc. | Healthcare | 0.10% | $105,564.43 | $10.46B | 25.6 |
| 58 | PODD | Insulet Corporation | Healthcare | 0.10% | $105,027.48 | $9.79B | 26.4 |
| 59 | UHS | Universal Health Services, Inc. | Healthcare | 0.09% | $99,335.80 | $10.91B | 7.6 |
| 60 | HSIC | Henry Schein, Inc. | Healthcare | 0.08% | $86,019.44 | $9.63B | 25.2 |
| 61 | DVA | DaVita Inc. | Healthcare | 0.06% | $64,970.99 | $11.95B | 15.8 |
Weights as a percentage of net assets. Value held = weight × net assets ($107.4M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
RXL sector breakdown
Sum of the weights of the holdings in each sector.
RXL top industries
RXL overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| XLV | Health Care Select Sector SPDR Fund | 63.0% | 60 of 60 | 0.09% |
| VHT | Vanguard Health Care ETF | 63.0% | 60 of 406 | 0.10% |
| TRUH | VanEck Healthcare TruSector ETF | 63.0% | 60 of 60 | — |
| IXJ | iShares Global Healthcare ETF | 63.0% | 60 of 106 | 0.42% |
| FHLC | Fidelity MSCI Health Care ETF | 63.0% | 60 of 334 | 0.07% |
| IYH | iShares U.S. Healthcare ETF | 59.1% | 55 of 99 | 0.39% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the RXL portfolio
ProShares Ultra Health Care holds 61 positions. The ten largest make up 49.7% of the fund and the top 50 75.2%, so it behaves like a portfolio of about 14 equally weighted stocks. The biggest positions are Proshares Genius Money Market ETF (13.47%), Eli Lilly and Company (9.95%), Johnson & Johnson (6.05%), AbbVie Inc. (4.90%), UnitedHealth Group Incorporated (3.71%).
By sector, Healthcare is 63.0%, Other is 13.5%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: RXL chart, RXL performance, RXL dividends, RXL valuation, RXL overview.
RXL holdings FAQ
How many holdings does RXL have?
RXL holds 61 positions as of October 25, 2026.
What are the top 10 holdings of RXL?
The ten largest holdings are Proshares Genius Money Market ETF (13.47%), Eli Lilly and Company (9.95%), Johnson & Johnson (6.05%), AbbVie Inc. (4.90%), UnitedHealth Group Incorporated (3.71%), Merck & Co., Inc. (3.36%), Thermo Fisher Scientific Inc. (2.37%), Amgen Inc. (2.24%), Gilead Sciences, Inc. (1.90%), Abbott Laboratories (1.76%). Together they are 49.7% of the fund.
What percentage of RXL is Proshares Genius Money Market ETF?
Proshares Genius Money Market ETF is the largest holding at 13.47% of net assets, about $14.5M of the fund's $107.4M.
How concentrated is RXL?
The top 10 holdings are 49.7% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) RXL behaves like a portfolio of about 14 equally weighted stocks.